Byong H. Kang
NKT Therapeutics (United States)
ORCID: 0000-0002-1637-2082Also affiliated with Xilio Therapeutics (United States)
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 7 papers. Top paper: “A replication-competent adenovirus-vectored influenza vaccine induces durable systemic and mucosal immunity”.
Stephen A. Migueles, Jinghe Huang, Lyuba Bolkhovitinov, Sarah Stuccio, Trevor Griesman +23 more
Coralie M. Backlund, Duncan M. Morgan, Byong H. Kang, Nishant K. Singh, Brooke D. Huisman +15 more
Yang Su, Byong H. Kang, Zhongqi Fan, Ting Dong, Douglas Brown +4 more
Coralie M. Backlund, Duncan M. Morgan, Byong H. Kang, Nishant K. Singh, Brooke D. Huisman +15 more
Byong H. Kang, Oleksandr Kyrysyuk, Shiwei Zheng, Hao Wang, Nathan D. Mathewson +9 more
Noor Jailkhani, Noor Momin, Ying Huang, Allison Sheen, Byong H. Kang +3 more
Joseph R. Palmeri, Emi A. Lutz, Noor Jailkhani, Howard H. Mak, Anthony Tabet +6 more